Protección de la Competencia en Chile: El Estado y Laboratorios Chile y Recalcine (1992-93)

Edgardo Barandiarán and Ricardo Paredes ()

No 222, Documentos de Trabajo from Instituto de Economia. Pontificia Universidad Católica de Chile.

Abstract: In 1992, Laboratorios Chile and Recalcine, the two largest pharmaceutical companies in Chile with a share of 82% of the domestic markets for generic products, were accused of collusion. The paper analyzes the process and the evidence considered by the Antitrust Commissions to assess the extent to which the Chilean system has been able to provide seguridad jurídica for market competition. Albeit economic models were readily available to argue the case, the process failed to generate the evidence necessary to apply them properly. The opposite decisions of the two Commissions reflected this failure and differences in the standards of proof. The analysis is useful, however, to understand the behavior and performance of the Chilean system of competition law.

Keywords: Antitrust; collusion (search for similar items in EconPapers)
JEL-codes: K21 K41 (search for similar items in EconPapers)
Date: 2002
References: View references in EconPapers View complete reference list from CitEc
Citations:

Downloads: (external link)
https://www.economia.uc.cl/docs/doctra/dt-222.pdf (application/pdf)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:ioe:doctra:222

Access Statistics for this paper

More papers in Documentos de Trabajo from Instituto de Economia. Pontificia Universidad Católica de Chile. Contact information at EDIRC.
Bibliographic data for series maintained by Jaime Casassus ().